In an audience packed with senior R&D leadersincluding over 10 from Eli Lilly, alongside key figures from Novo Nordisk, AstraZeneca, Roche, Boehringer Ingelheim, and others the realization dawned that a traditional pharma giant had officially evolved into the first longevity pharma company
1.3 The established role of GLP-1 receptor agonists in obesity and T2D Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were originally introduced as therapeutic agents for T2D
Being able to regularly attend appointments, undergo testing, and have face-to-face support makes accountability stronger
Caring for patients with chronic diseases will require a multi-pronged approach to ensure improved health outcomes
Saxenda Saxenda, another weight loss drug manufactured by Novo Nordisk, is prescribed for patients to treat obesity and other chronic weight management needs
Glyteine is the body's natural precursor to glutathione (see figure 3) and the only product on the market that can efficiently raise cellular glutathione by bypassing this defective enzyme